The global oligonucleotide synthesis market growth in 2026 is expanding rapidly as pharmaceutical companies, biotechnology firms, and research institutions increasingly use synthetic DNA and RNA sequences for drug development, molecular diagnostics, and genomic research. According to Fortune Business Insights, the global oligonucleotide synthesis market size was valued at USD 10.78 billion in 2025. The market is projected to grow from USD 12.81 billion in 2026 to USD 50.84 billion by 2034, exhibiting a compound annual growth rate (CAGR) of 18.8% during the forecast period. North America dominated the market with a 40% revenue share in 2025.
Oligonucleotide synthesis involves producing short, precisely defined DNA or RNA sequences for use in scientific research and commercial applications. These sequences are essential components in polymerase chain reaction (PCR), DNA sequencing, gene editing, molecular diagnostics, and nucleic acid-based therapeutics. Growing investment in genomics and precision medicine is increasing demand for customized oligonucleotides with high purity and sequence accuracy.
Key companies operating in the global oligonucleotide synthesis market include:
These companies support the market through custom synthesis services, research products, manufacturing capabilities, and specialized oligonucleotide solutions. Competition increasingly depends on product quality, turnaround times, production capacity, and the ability to supply customized sequences for research and therapeutic applications.
Increasing demand for nucleic acid-based therapeutics: Pharmaceutical and biotechnology companies are developing treatments that use oligonucleotides, including antisense oligonucleotides and small interfering RNA (siRNA). These approaches are expanding the need for reliable synthesis services and high-quality materials suitable for research, clinical development, and commercial production.
Expansion of genomic research and molecular diagnostics: Oligonucleotides are widely used as primers and probes in PCR, DNA sequencing, and hybridization-based testing. Increasing research activity in genomics, genetic mutations, and molecular biology is supporting demand from research institutes and diagnostic laboratories.